- Trials with a EudraCT protocol (10,988)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (18,700)
10,988 result(s) found.
Displaying page 144 of 550.
EudraCT Number: 2010-021515-17 | Sponsor Protocol Number: N/A | Start Date*: 2010-09-30 | |||||||||||
Sponsor Name:Imperial College London | |||||||||||||
Full Title: RiFL: Rifaxamin in Fatty Liver Disease. Does Modulation of Gut Microbiota Reduce Hepatic Inflammation in Non-Alcoholic Steatohepatitis (NASH)? | |||||||||||||
Medical condition: Non-alcoholic steatohepatitis (NASH) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-022817-24 | Sponsor Protocol Number: OVG 2010/03 | Start Date*: 2010-10-18 | |||||||||||
Sponsor Name:University of Oxford | |||||||||||||
Full Title: A multi-centre, open-label, clinical, phase 4 trial, following on from a head-to-head comparison study of two H1N1 influenza vaccines in children, to compare firstly, the persistence of antibody ag... | |||||||||||||
Medical condition: Prevention of Influenza infections | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-005717-38 | Sponsor Protocol Number: D8480C00046 | Start Date*: 2006-08-15 |
Sponsor Name:AstraZeneca AB | ||
Full Title: An Open-Label, Phase II Study to Evaluate the Biological Activity of AZD2171, as Measured by FDG-PET Response, in Patients with Metastatic Gastro-Intestinal Stromal Tumours (GIST) Resistant or Into... | ||
Medical condition: Metastatic Gastro-Intestinal Stromal Tumours | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2008-007322-19 | Sponsor Protocol Number: RPC190 | Start Date*: 2009-07-07 |
Sponsor Name:Queen Victoria Hospital NHS Foundation Trust | ||
Full Title: A Comparison of Remifentanil Patient-Controlled Analgesia vs. Oral Morphine Analgesia for Dressing Changes in Burns Patients. | ||
Medical condition: Pain experienced by patients with pre-existing burns presenting to the burns outpatients unit requiring two or more dressing changes | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2008-003727-23 | Sponsor Protocol Number: RRK3563 | Start Date*: 2008-12-16 | |||||||||||
Sponsor Name:University Hospital Birmingham NHS Foundation Trust | |||||||||||||
Full Title: Does phosphate binding with sevelamer carbonate improve cardiovascular structure and function in patients with early chronic kidney disease? | |||||||||||||
Medical condition: Chronic kidney disease stage 3 (eGFR 30-59 ml/min/1.73m2) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-021813-22 | Sponsor Protocol Number: 781875 | Start Date*: 2010-12-23 | |||||||||||
Sponsor Name:Central Manchester University Hospitals NHS Foundation Trust | |||||||||||||
Full Title: The Anticoagulation of Calf Thrombosis (ACT) Study: A randomised controlled trial comparing standardised anticoagulation versus conservative therapy in the treatment of below knee deep vein thrombo... | |||||||||||||
Medical condition: DVT of the calf / below knee region. | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-012928-89 | Sponsor Protocol Number: 1.1042009 | Start Date*: 2009-10-21 | |||||||||||
Sponsor Name:South Tees NHS Trust | |||||||||||||
Full Title: Intrathecal injection of a single dose of Ziconotide (Prialt®) to evaluate the option of continuous administration via implanted pump. A Pilot Study | |||||||||||||
Medical condition: Severe, Chronic pain in patients who require intrathecal analgesia | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-019647-19 | Sponsor Protocol Number: MAC_001 | Start Date*: 2011-02-04 |
Sponsor Name:University of Oxford | ||
Full Title: A double blind randomised placebo controlled trial of montelukast in the treatment of acute persistent cough in young people and adults (aged 16-49) in primary care | ||
Medical condition: Acute persistent cough with no established diagnosis | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2008-008441-38 | Sponsor Protocol Number: ISRCTN76912190 | Start Date*: 2011-02-17 | |||||||||||
Sponsor Name:London School Of Hygiene and Tropical Medicine | |||||||||||||
Full Title: Tranexamic acid for the treatment of postpartum haemorrhage: An international randomised, double blind, placebo controlled trial | |||||||||||||
Medical condition: Postpartum haemorrhage | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-007984-17 | Sponsor Protocol Number: PETC1002 | Start Date*: 2009-03-02 | |||||||||||
Sponsor Name:Moorfields Eye Hospital NHS Foundation Trust | |||||||||||||
Full Title: Pilot randomised placebo-controlled double-masked clinical trial of subconjunctival Bevacizumab on eyes with recent onset of corneal neovascularisation | |||||||||||||
Medical condition: Corneal neovascularisation | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-007319-33 | Sponsor Protocol Number: OP08/8679 | Start Date*: 2009-02-19 |
Sponsor Name:Leeds Teaching Hospitals NHS Trust | ||
Full Title: Do genes predict response to treatment in age-related macular degeneration? | ||
Medical condition: Choroidal neovascularisation secondary to age-related macular degeneration (ARMD) | ||
Disease: | ||
Population Age: Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2010-021630-63 | Sponsor Protocol Number: GA1001 | Start Date*: 2011-03-28 |
Sponsor Name:Reckitt Benckiser | ||
Full Title: A randomised, double blind placebo controlled study in patients with reflux symptoms to assess suppression of gastro-oesophageal reflux by ‘Gaviscon Double Action Peppermint liquid’ using the BRAVO... | ||
Medical condition: Gastro-oesophageal reflux disease (GORD) | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2005-004833-17 | Sponsor Protocol Number: CBD VP 128/05 | Start Date*: 2009-05-01 |
Sponsor Name:Dstl | ||
Full Title: Assessment of the effect of prior anthrax vaccine precipitated (AVP) vaccination on the immune response to booster AVP vaccination. | ||
Medical condition: Vaccination against potential exposure to anthrax (Bacillus anthracis). | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2009-016223-56 | Sponsor Protocol Number: 2478-INT-001 | Start Date*: 2010-09-02 | |||||||||||
Sponsor Name:Kyowa Hakko Kirin Pharma, Inc. | |||||||||||||
Full Title: An Open-Label, Dose Escalation, Multicenter Phase 1/2 Study of KW-2478 in Combination with Bortezomib in Subjects with Relapsed and/or Refractory Multiple Myeloma | |||||||||||||
Medical condition: Multiple Myeloma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-000087-83 | Sponsor Protocol Number: 2929 | Start Date*: 2008-12-19 | ||||||||||||||||
Sponsor Name:University of Liverpool [...] | ||||||||||||||||||
Full Title: EUROPAC2 trial to investigate the efficacy of ANTOX(vers) 1.2 and MGCT (magnesiocard) for the treatment of hereditary pancreatitis and idiopathic chronic pancreatitis. | ||||||||||||||||||
Medical condition: Hereditary Pancreatitis and Idiopathic Chronic Pancreatitis | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-000493-23 | Sponsor Protocol Number: A2260335 | Start Date*: 2007-04-05 |
Sponsor Name:GlaxoSmithKline Consumer Healthcare | ||
Full Title: A Comparison of Two Analgesic Products for the Treatment of Headache | ||
Medical condition: Treatment of tension headache | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2010-023910-30 | Sponsor Protocol Number: RR10/9592 | Start Date*: 2011-03-23 | |||||||||||
Sponsor Name:University of Leeds | |||||||||||||
Full Title: A Prospective, Single-centre, Randomised Study Evaluating the Clinical, Imaging and Immunological Depth of Remission Achieved by Very Early versus Delayed Etanercept in patients with Rheumatoid Art... | |||||||||||||
Medical condition: Rheumatoid Arthritis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-012043-42 | Sponsor Protocol Number: RSCH 01/10 | Start Date*: 2011-07-11 | ||||||||||||||||
Sponsor Name:Royal Surrey County Hospital NHS Trust | ||||||||||||||||||
Full Title: The Effect of a Human Surgical Sealant on Range of Motion in Total Knee Replacement | ||||||||||||||||||
Medical condition: Use of human surgical sealant during total knee replacement and if this affects knee movement for the 1st year after surgery. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Prematurely Ended) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-002405-47 | Sponsor Protocol Number: The CogNaive Study | Start Date*: 2007-07-31 |
Sponsor Name:Imperial College | ||
Full Title: A randomised prospective study assessing changes in neuro-cognitive function, using a computerised test battery, in treatment naïve HIV-1 positive subjects commencing two different antiretroviral r... | ||
Medical condition: HIV | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2010-021886-63 | Sponsor Protocol Number: RD2010-48 | Start Date*: 2011-07-14 | |||||||||||
Sponsor Name:East and North Hertfordshire NHS Trust [...] | |||||||||||||
Full Title: A trial of Prostate Radiotherapy in Conjunction with Carbogen and Nicotinamide (PROCON) | |||||||||||||
Medical condition: Prostate Cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
